Menu
Close
Close
Industries

Life sciences

Supporting the increased drive for earlier diagnosis of disease, personalised medicine and new drugs and treatments

We are accelerating innovation and implementation, whilst maintaining safety and confidence

The UK is contending with the effect that changing demographics will make to the quality of UK healthcare. An ageing population, increasing antibiotic resistance, more people with chronic illnesses and lifestyle factors are all proving challenging to this innovative and dynamic sector.

Advances in genetics and molecular biology mean we have a better understanding of the complex causes of diseases and have the ability to design treatments that are tailor-made for individual patients. But drug development is still expensive and painstaking, and is slowing the development of much needed medicine. 

NPL is working to tackle some of the world’s biggest health challenges, from reducing attrition rates in drug development to treating cancer and dementia, as well as creating new antibiotics. We work with manufacturers of diagnostic equipment and medical devices, government, researchers and pharamaceutical companies to standardise and improve diagnosis and treatment techniques.

Contact us

Our expertise

NPL undertakes focused research and development, as well as providing services and bespoke consultancy in the following areas:

Building a 'Google Earth' of cancer

Find out how our work with the Cancer Research UK initiative aims to overcome the biggest challenges facing cancer researchers in a global effort to beat cancer sooner.  

Building a 'Google Earth' of cancer

Case study

Using visualisation to develop more effective antibiotics

Article

Case study

Using protein rulers to calibrate high-resolution microscopes

Article

Case study

Supporting the UK biotechnology industry

Article

Our research

Find out more about our research into life sciences.

Find out how we can help you

Working with us opens the door to state-of-the-art facilities and over 500 passionate scientists with world-class measurement capabilities.